CD274 and breast carcinoma: Also, to assesspotential HSA-DTX@PEG-DVL-induced changes in PD-L1 protein expressionin breast cancer cells, MDA-MB-231 and MCF-7 cells were treated withthe nanostructure form (7.5 μg/mL) for 24 h and analyzed.